Literature DB >> 1365625

Effects of ketanserin and mianserin on delayed neuronal death induced by cerebral ischemia in Mongolian gerbils.

Y Karasawa1, H Araki, S Otomo.   

Abstract

We examined whether ketanserin and mianserin, drugs with 5-HT2 receptor antagonistic effects, would have protective effects in Mongolian gerbils on delayed neuronal death induced by cerebral ischemia. When training and test sessions in the passive avoidance task were carried out 6 and 7 days after 3 min of ischemia, passive avoidance impairment was apparent. Destruction and disappearance was apparent in the hippocampal CA1 neurons at 7 days after the induced ischemia. Administration of ketanserin (5-20 mg/kg) and mianserin (5-20 mg/kg) led to better passive avoidance and prevented the delayed neuronal death induced by the ischemia. These effects of ketanserin and mianserin were not inhibited by treatment with the cholinergic blocker scopolamine (5 mg/kg). Thus, ketanserin and mianserin have a protective effect on delayed neuronal death in gerbils and the effects of these drugs are not mediated by serotonergic and cholinergic systems.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1365625     DOI: 10.1007/bf02245872

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  30 in total

Review 1.  Neurotransmitters and the normal and ischemic cerebral circulation.

Authors:  N T Zervas; M H Lavyne; M Negoro
Journal:  N Engl J Med       Date:  1975-10-16       Impact factor: 91.245

2.  Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate.

Authors:  J W Olney
Journal:  Science       Date:  1969-05-09       Impact factor: 47.728

3.  Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.

Authors:  J E Leysen; F Awouters; L Kennis; P M Laduron; J Vandenberk; P A Janssen
Journal:  Life Sci       Date:  1981-03-02       Impact factor: 5.037

4.  Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.

Authors:  J E Leysen; W Gommeren; P Van Gompel; J Wynants; P F Janssen; P M Laduron
Journal:  Mol Pharmacol       Date:  1985-06       Impact factor: 4.436

5.  Transient forebrain ischemia of three-minute duration consistently induces severe neuronal damage in field CA1 of the hippocampus in the normothermic gerbil.

Authors:  A Mitani; Y Andou; S Masuda; K Kataoka
Journal:  Neurosci Lett       Date:  1991-10-14       Impact factor: 3.046

6.  Fine structural nature of delayed neuronal death following ischemia in the gerbil hippocampus.

Authors:  T Kirino; K Sano
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

7.  Experimental cerebral ischemia in mongolian gerbils. I. Light microscopic observations.

Authors:  U Ito; M Spatz; J T Walker; I Klatzo
Journal:  Acta Neuropathol       Date:  1975-08-27       Impact factor: 17.088

8.  Serotonergic facilitation of facial motoneuron excitation.

Authors:  R B McCall; G K Aghajanian
Journal:  Brain Res       Date:  1979-06-15       Impact factor: 3.252

9.  Effect of minaprine and other reference drugs on passive avoidance impairment induced by cerebral ischemia in Mongolian gerbils.

Authors:  Y Karasawa; H Araki; S Okuyama; H Aihara; S Otomo
Journal:  Jpn J Pharmacol       Date:  1990-07

10.  Lesions to Schaffer collaterals prevent ischemic death of CA1 pyramidal cells.

Authors:  H Onodera; G Sato; K Kogure
Journal:  Neurosci Lett       Date:  1986-07-24       Impact factor: 3.046

View more
  2 in total

Review 1.  Sleep Disorders in Stroke: An Update on Management.

Authors:  Hongxia Cai; Xiao-Ping Wang; Guo-Yuan Yang
Journal:  Aging Dis       Date:  2021-04-01       Impact factor: 6.745

2.  Clinically approved heterocyclics act on a mitochondrial target and reduce stroke-induced pathology.

Authors:  Irina G Stavrovskaya; Malini V Narayanan; Wenhua Zhang; Boris F Krasnikov; Jill Heemskerk; S Stanley Young; John P Blass; Abraham M Brown; M Flint Beal; Robert M Friedlander; Bruce S Kristal
Journal:  J Exp Med       Date:  2004-07-19       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.